低场强术中MRI在经蝶垂体腺瘤手术中应用10年经验:瑞士垂体登记研究(SwissPit)结果
该回顾性研究纳入2006至2016年间在作者机构接受低场强(0.15T)术中MRI控制的内镜辅助经蝶垂体腺瘤手术的231例患者,随访62个月(9-178个月)。术中MRI引导的额外切除在54%患者中可行,使全切除率提高4%(P=0.004)。结论认为低场强术中MRI可提高切除率并持续影响结局。
要点
- 低场强术中MRI引导的额外切除在54%患者中可行,全切除率提高4%(P=0.004)。
- 无功能腺瘤缓解率53%,肢端肥大症61%,泌乳素瘤50%,库欣病90%。
- 术后新发激素缺乏风险为15%,视觉视野和视力缺陷术后缓解率分别为86%和81%。
核心结论
- 基于对超过200例无功能/功能性垂体腺瘤的长期随访,低场强术中MRI在经蝶手术中提高切除率并持续影响结局。
研究设计与样本
- 回顾性研究,纳入2006至2016年间在作者机构接受术中MRI控制的内镜辅助经蝶垂体腺瘤手术的患者,数据收集于瑞士垂体登记研究(SwissPit),使用Polestar 0.15T扫描仪。
- 共231例患者,包括160例无功能腺瘤、28例hGH分泌腺瘤、27例PRL分泌腺瘤、10例ACTH分泌腺瘤和6例混合腺瘤,随访62个月(9-178个月)。
主要发现
- 术中MRI引导的额外切除在54%患者中可行,使全切除率提高4%(P=0.004)。
- 缓解率:无功能腺瘤53%,肢端肥大症61%,泌乳素瘤50%,库欣病90%。
- 肿瘤再生长和复发分别在中位时间24个月和63个月被检测到。
- 缺陷激素轴恢复在22%至27%患者中检测到,术后新发激素缺乏风险为15%。
- 术后视觉视野和视力缺陷缓解分别见于94例(86%)和73例(81%)患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For 20 years, several studies have reported intraoperative magnetic resonance imaging (iMRI) utility to achieve gross total resections in transsphenoidal pituitary adenoma surgery. Although few studies on low-field iMRI included >100 patients, data on hormonally active tumors remain scarce and follow-up times are <3 years. This is not sufficient to judge the long-term efficiency of the use of low-field iMRI. The aim of this retrospective study is to report the detailed outcome of iMRI-controlled transsphenoidal surgery in >200 patients during a follow-up exceeding 5 years. METHODS: Patients undergoing surgery for pituitary adenoma by iMRI-controlled, endoscopically assisted transsphenoidal surgery at the authors' institution between 2006 and 2016 were eligible for inclusion. Data were collected in the Swiss Pituitary Registry. A Polestar 0.15T-scanner was used. RESULTS: A total of 231 patients had surgery for 160 nonfunctioning adenomas; 28 hGH-, 27 PRL-, 10 ACTH-secreting and 6 mixed adenomas and were followed for 62 months (9-178). Additional iMRI-guided resections were possible in 54% and increased the gross total resection rate by 4% (P = 0.004). Remission rates were as follows: nonfunctioning adenoma, 53%; acromegaly, 61%; prolactinoma, 50%; Cushing disease, 90%. Tumor regrowth and recurrence was detected at a mean time of 24 and 63 months, respectively. Recovery of deficient hormone axes was detected in 22% to 27%. The risk for new postoperative hormonal deficiencies was 15%. Postoperative relieve of visual field and visual acuity deficiencies was seen in 94 (86%) and 73 (81%) patients, respectively. CONCLUSION: Judged by long-term follow-ups of >200 nonfunctioning/functioning pituitary adenomas, the use of low-field iMRI in transsphenoidal surgery increases resection rates and sustainably influences outcomes.
引用
- Strange F, Remonda L, Schütz P, et al. 10 Years' Experience of Using Low-Field Intraoperative MRI in Transsphenoidal Surgery for Pituitary Adenoma: Results of the Swiss Pituitary Registry (SwissPit). World Neurosurg. 2019. PMID: 31899402. doi:10.1016/j.wneu.2019.12.146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。